Clinical Trial Update: Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the accuracy of contrast-enhanced ultrasound for hepatocellular carcinoma after transarterial chemoembolization has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2023-11-02